CONNIE MATSUI - 28 Oct 2025 Form 4 Insider Report for ARTELO BIOSCIENCES, INC. (ARTL)

Role: Director
Signature: /s/ Gregory D. Gorgas, as Attorney-in-Fact
Issuer symbol: ARTL
Transactions as of: 28 Oct 2025
Net transactions value: -$29,157
Form type: 4
Filing time: 30 Oct 2025, 21:30:05 UTC
Previous filing: 16 Oct 2025
Next filing: 29 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
MATSUI CONNIE	Director	C/O ARTELO BIOSCIENCES, INC., 505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH	/s/ Gregory D. Gorgas, as Attorney-in-Fact	30 Oct 2025	0001236537

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARTL	Convertible Promissory Note	Conversion of derivative security	$140,000		$0	28 Oct 2025	Common Stock			Direct	F1, F2
transaction	ARTL	Warrant (right to buy)	Conversion of derivative security		+38,346	38,346	28 Oct 2025	Common Stock	38,346	$6.24	Direct	F1, F2
transaction	ARTL	Warrant (right to buy)	Conversion of derivative security		+70,376	70,376	28 Oct 2025	Common Stock	70,376	$3.40	Direct	F1, F2
transaction	ARTL	Convertible Promissory Note	Conversion of derivative security	$110,843		$110,843	28 Oct 2025	Common Stock		$3.40	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the "May Note"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock ("Common Stock") (the "$6.24 Warrant").
F2	On October 28, 2025, the Issuer entered into a Subscription Agreement (the "Subscription Agreement") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the "October Note"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the "$3.40 Warrant"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock.

Content

Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the "May Note"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock ("Common Stock") (the "$6.24 Warrant").

On October 28, 2025, the Issuer entered into a Subscription Agreement (the "Subscription Agreement") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the "October Note"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the "$3.40 Warrant"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock.